JP2002506631A - 抗イノシトールホスホグリカンモノクローナル抗体 - Google Patents

抗イノシトールホスホグリカンモノクローナル抗体

Info

Publication number
JP2002506631A
JP2002506631A JP2000536756A JP2000536756A JP2002506631A JP 2002506631 A JP2002506631 A JP 2002506631A JP 2000536756 A JP2000536756 A JP 2000536756A JP 2000536756 A JP2000536756 A JP 2000536756A JP 2002506631 A JP2002506631 A JP 2002506631A
Authority
JP
Japan
Prior art keywords
ipg
antibody
type
ipgs
binding
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2000536756A
Other languages
English (en)
Japanese (ja)
Inventor
イザベル・ヴァレラ・ニエト
ホセ・マト
ジーザス・プリエト
フィリップ・ウィリアムズ
トーマス・ウィリアム・レイドメイチャー
Original Assignee
レイドメイチャー・グループ・リミテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9805739.1A external-priority patent/GB9805739D0/en
Priority claimed from GBGB9811000.0A external-priority patent/GB9811000D0/en
Application filed by レイドメイチャー・グループ・リミテッド filed Critical レイドメイチャー・グループ・リミテッド
Publication of JP2002506631A publication Critical patent/JP2002506631A/ja
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Obesity (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
JP2000536756A 1998-03-18 1999-03-18 抗イノシトールホスホグリカンモノクローナル抗体 Withdrawn JP2002506631A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB9805739.1 1998-03-18
GBGB9805739.1A GB9805739D0 (fr) 1998-03-18 1998-03-18
GB9811000.0 1998-05-21
GBGB9811000.0A GB9811000D0 (fr) 1998-05-21 1998-05-21
PCT/GB1999/000844 WO1999047565A1 (fr) 1998-03-18 1999-03-18 Anticorps monoclonaux anti-inositolphosphoglyanne

Publications (1)

Publication Number Publication Date
JP2002506631A true JP2002506631A (ja) 2002-03-05

Family

ID=26313300

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000536756A Withdrawn JP2002506631A (ja) 1998-03-18 1999-03-18 抗イノシトールホスホグリカンモノクローナル抗体

Country Status (5)

Country Link
EP (1) EP1062246A1 (fr)
JP (1) JP2002506631A (fr)
AU (1) AU748080B2 (fr)
CA (1) CA2321113A1 (fr)
WO (1) WO1999047565A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2355468A1 (fr) * 1998-12-24 2000-07-06 University College London Proteines d phospholipase specifiques du glycosyl phosphatidy linositol et leurs utilisations
WO2001086292A2 (fr) * 2000-05-12 2001-11-15 Rodaris Pharmaceutical Limited Dosages biologiques

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9505658D0 (en) * 1995-03-21 1995-05-10 Univ London Hormone and growth factor mimetics
GB9618929D0 (en) * 1996-09-11 1996-10-23 Univ London Metal containing carbohydrates from human tissue which regulate glycogen metabolism
GB9618931D0 (en) * 1996-09-11 1996-10-23 Univ London Inositol phosphoglycans for therapeutic use in pre-eclampsia and diabetes
GB9618930D0 (en) * 1996-09-11 1996-10-23 Univ London Metal containing carbohydrates from human tissue which regulate lipogenic activity
GB9618934D0 (en) * 1996-09-11 1996-10-23 Univ London Inositol phosphoglycans for therapeutic use in the treatment of diabetes and obesity

Also Published As

Publication number Publication date
WO1999047565A1 (fr) 1999-09-23
AU748080B2 (en) 2002-05-30
CA2321113A1 (fr) 1999-09-23
EP1062246A1 (fr) 2000-12-27
AU2946799A (en) 1999-10-11

Similar Documents

Publication Publication Date Title
KR101701300B1 (ko) 항­ｐ２ｘ７ 펩티드 및 에피토프
BR112020004231A2 (pt) anticorpos anti-cd166 ativáveis e métodos de uso dos mesmos
JP2001501920A (ja) ヒトｖｅｇｆ受容体タンパク質（ｋｄｒ）の細胞外ドメインに対するモノクローナル抗体
EA025218B1 (ru) Способ диагностики злокачественных новообразований, экспрессирующих рецептор her2 или его укороченные варианты
US9783600B2 (en) Apolipoprotein C3 (ApoCIII) antagonists and methods of their use to remove ApoCIII inhibition of lipoprotein lipase (LPL)
JP5847755B2 (ja) 細胞を検出する方法、およびこれに有用な薬剤
WO2006116631A2 (fr) Anticorps de l'isoforme de l'antigene nucleaire des cellules proliferatives cancereuses specifiques (pcnacs) et leurs utilisations
JP2001501598A (ja) 子癇前症および糖尿病の診断および処置に関する材料および方法
JP5893037B2 (ja) Ｂｒａｆｖ６００ｅに特異的に結合する抗体を使用する癌の診断のための手段及び方法
JP2001505658A (ja) 糖尿病及び肥満症の診断及び治療に関する物質及び方法
KR20080106157A (ko) Ｆａｓ 결합 항체
JP2007536212A (ja) レプチンアンタゴニストおよびレプチン定量測定方法
JPH09507578A (ja) インスリン受容体チロシンキナーゼインヒビターに対するアンタゴニスト
US20240174762A1 (en) Methods, compositions and uses for targeting sema7a in the diagnosis and treatment of health conditions
US7732147B2 (en) Neurotransmission disorders
JP2001519894A (ja) リソソーム蓄積症の早期検出法
UA121047C2 (uk) Антитіло до igf-1r та його застосування для діагностики раку
JP2002506631A (ja) 抗イノシトールホスホグリカンモノクローナル抗体
JP2023553247A (ja) がん診断のための組成物および方法
KR20230073574A (ko) 외부 칼슘 유입 이상에 기인된 골격근 질환의 진단 및 예방 또는 치료를 위한 casq1-stim2 결합의 용도
EP1701166A1 (fr) SP1 comme marqueur pour le diagnostic et le pronostic de stéato-hépatite non alcoolique (nash) et objectif pour le criblage de drogue pour nash
US20040192586A1 (en) Materials and methods relating to anti-inositolphosphoglycan antibodies
JP5749643B2 (ja) 診断及び予後の方法を実施するためのｉｒａｐタンパク質の使用
JP2002507724A (ja) イノシトールホスホグリカン模倣物の同定に関する材料と方法
Standop et al. ErbB2 oncogene expression supports the acute pancreatitis–chronic pancreatitis sequence

Legal Events

Date Code Title Description
A300 Withdrawal of application because of no request for examination

Free format text: JAPANESE INTERMEDIATE CODE: A300

Effective date: 20060606